RT Journal Article
SR Electronic
T1 The potential of SARS-CoV-2 antigen-detection tests in the screening of asymptomatic persons
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.06.07.21258465
DO 10.1101/2021.06.07.21258465
A1 Jonas Wachinger
A1 Ioana Diana Olaru
A1 Susanne Horner
A1 Paul Schnitzler
A1 Klaus Heeg
A1 Claudia M. Denkinger
YR 2021
UL http://medrxiv.org/content/early/2021/06/10/2021.06.07.21258465.abstract
AB Objectives To assess the performance of antigen-based rapid diagnostic tests (Ag-RDTs) for SARS CoV-2 when implemented for large-scale universal screening of asymptomatic individuals.Methods This study presents data from a pragmatic implementation study for universal Ag-RDT-based screening at a tertiary care hospital in Germany where all incoming patients without symptoms suggestive of SARS-CoV-2 were screened with an Ag-RDT prior to admission since October 2020.Result In total, 49,542 RDTs were performed in 27,199 asymptomatic individuals over a duration of five months. Out of 222 positive results, 196 underwent in-house confirmatory testing with PCR, out of which 170 were confirmed positive, indicating a positive predictive value (PPV) of 86.7%. Negative Ag-RDTs were not routinely tested with PCR, but a total of 94 cases of false negative Ag-RDTs were detected due to PCR tests being performed within the following five days with a median CT-value of 33.Conclusions This study provides evidence that Ag-RDTs can have a high diagnostic yield for transmission relevant infections with limited false-positives when utilized at the point of care on asymptomatic patients and thus can be a suitable public-health test for universal screening.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialDRKS00023584Funding StatementThis study was funded in part by the Ministry of Science, Research and the Arts of Baden-Wuerttemberg, Germany, as well as hospital-internal funds.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The ethical review board of the Medical Faculty, Heidelberg University, Germany, approved this study (S-811/2020)All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesDatasets used and/or analysed during the current study are available from the corresponding author on reasonable request. However, to preserve the anonymity of respondents and considering the personal nature of this data, requests will be considered on a case-by-case basis.